FindTrial
Sign In

A Clinical Study of Early Identification of Cardiac Dysfunction in Chronic Thromboembolic Pulmonary Disease by Cardiac Magnetic Resonance

A Clinical Study of Early Identification of Cardiac Dysfunction in Chronic Thromboembolic Pulmonary Disease by Cardiac Magnetic Resonance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097491
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-02-25
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Thromboembolic Pulmonary Disease

Interventions

PTE group:None
normal group:None
CTEPH group:None

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age=18 years; 2.a clear diagnosis of pulmonary thromboembolism by CTPA; 3.Standardized anticoagulation for more than 3 months;

Exclusion criteria

Exclusion criteria: 1.There are any contraindications to cardiac magnetic resonance examination, such as pacemaker, claustrophobia, etc. 2.Structural heart disease, e.g. congenital heart disease, valvular disease (without mild valvular regurgitation); 3.Cardiomyopathy; 4.heart failure with reduced ejection fraction due to various causes (left ventricular ejection fraction <50%); 5.Significant arrhythmias, e.g., atrial fibrillation, frequent premature contractions; 6.Resting pulmonary hypertension; 7.Refusal to sign Informed consent;

Design outcomes

Primary

MeasureTime frame
Hemodynamic Forces;—

Secondary

MeasureTime frame
Strain;Geometry;—

Countries

China

Contacts

Public ContactYaodan Liang

Beijing Hospital

liangyaodan001@126.com+86 10 85133875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026